» Articles » PMID: 35223380

Intracellular Vesicle Entrapment of Nanobubble Ultrasound Contrast Agents Targeted to PSMA Promotes Prolonged Enhancement and Stability and

Overview
Specialty Biotechnology
Date 2022 Feb 28
PMID 35223380
Authors
Affiliations
Soon will be listed here.
Abstract

Gas-core nanoscale bubbles (or nanobubbles) have gained significant recent attention as promising contrast agents for cancer molecular imaging using medical ultrasound. Previous work has shown that active targeting of nanobubbles to tumor biomarkers such as the prostate-specific membrane antigen (PSMA) significantly prolongs ultrasound signal enhancement, which is a critical feature for successful tumor diagnosis. However, the specific mechanism behind this effect is not well understood, and has not been previously studied in detail. Thus, in the current work, we investigated the process of PMSA- targeted nanobubble transport in tumors across different scales from whole tumor imaging using high-frequency dynamic contrast-enhanced ultrasound to intracellular confocal imaging and, molecularly using headspace gas chromatography/mass spectrometry. Data demonstrated that, indeed, molecular targeting of nanobubbles to the PSMA biomarker prolongs their tumor uptake and retention across the entire tumor volume, but with variability due to the expected tumor heterogeneity. Importantly, , the active targeting of NBs results in internalization via receptor-mediated endocytosis into the target cells, and the co-localization with intracellular vesicles (late-stage endosomes/lysosomes) significantly prolongs perfluorocarbon gas retention within the cells. This has not been directly observed previously. These results support the potential for nanobubbles to enable highly specific, background-free diagnostic imaging of the target cells/tissues using ultrasound.

Citing Articles

Assessing Therapeutic Nanoparticle Accumulation in Tumors Using Nanobubble-Based Contrast-Enhanced Ultrasound Imaging.

Cooley M, Wegierak D, Perera R, Abenojar E, Nittayacharn P, Berg F ACS Nano. 2024; 18(48):33181-33196.

PMID: 39566912 PMC: 11619768. DOI: 10.1021/acsnano.4c11805.


Nanobubble Contrast Enhanced Ultrasound Imaging: A Review.

Wegierak D, Nittayacharn P, Cooley M, Berg F, Kosmides T, Durig D Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024; 16(6):e2007.

PMID: 39511794 PMC: 11567054. DOI: 10.1002/wnan.2007.


Life at the interface: Engineering bio-nanomaterials through interfacial molecular self-assembly.

Miller M, Medina S Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024; 16(3):e1966.

PMID: 38725255 PMC: 11090466. DOI: 10.1002/wnan.1966.


Using imaging modalities to predict nanoparticle distribution and treatment efficacy in solid tumors: The growing role of ultrasound.

Cooley M, Wegierak D, Exner A Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024; 16(2):e1957.

PMID: 38558290 PMC: 11006412. DOI: 10.1002/wnan.1957.


Decorrelation Time Mapping as an Analysis Tool for Nanobubble-Based Contrast Enhanced Ultrasound Imaging.

Wegierak D, Cooley M, Perera R, Wulftange W, Gurkan U, Kolios M IEEE Trans Med Imaging. 2024; 43(6):2370-2380.

PMID: 38329864 PMC: 11234354. DOI: 10.1109/TMI.2024.3364076.


References
1.
Yan J, Yin M, Foster F, Demore C . Tumor Contrast Imaging with Gas Vesicles by Circumventing the Reticuloendothelial System. Ultrasound Med Biol. 2019; 46(2):359-368. DOI: 10.1016/j.ultrasmedbio.2019.09.009. View

2.
Junttila M, de Sauvage F . Influence of tumour micro-environment heterogeneity on therapeutic response. Nature. 2013; 501(7467):346-54. DOI: 10.1038/nature12626. View

3.
Castanares M, Mukherjee A, Chowdhury W, Liu M, Chen Y, Mease R . Evaluation of prostate-specific membrane antigen as an imaging reporter. J Nucl Med. 2014; 55(5):805-11. PMC: 4074907. DOI: 10.2967/jnumed.113.134031. View

4.
Genady A, Janzen N, Banevicius L, El-Gamal M, El-Zaria M, Valliant J . Preparation and Evaluation of Radiolabeled Antibody Recruiting Small Molecules That Target Prostate-Specific Membrane Antigen for Combined Radiotherapy and Immunotherapy. J Med Chem. 2016; 59(6):2660-73. DOI: 10.1021/acs.jmedchem.5b01881. View

5.
Wang H, Wang S, Song W, Pan Y, Yu H, Si T . Expression of prostate-specific membrane antigen in lung cancer cells and tumor neovasculature endothelial cells and its clinical significance. PLoS One. 2015; 10(5):e0125924. PMC: 4433228. DOI: 10.1371/journal.pone.0125924. View